Longeveron logo.jpg
Longeveron Inc. to Present at the Q1 Virtual Investor Summit on March 24
19 mars 2021 07h45 HE | Longeveron Inc.
MIAMI, March 19, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for...